Gibbel\'s announcement on the results of the third vesting period of the 2021 Restricted Stock Incentive Plan and stock listing
Inspection opinions of the board of supervisors of Jiangsu Jebel Pharmaceutical Co., Ltd. on the “List of Incentive Targets for the Third Vesting Period of the Company\'s 2021 Restricted Stock Incentive Plan”
Gibbel\'s announcement on the achievement of the vesting conditions for the third vesting period of the 2021 Restricted Stock Incentive Plan
Gibel\'s announcement on abolishing part of the 2021 Restricted Stock Incentive Plan and granted restricted shares that have not yet been owned
Legal Opinion of Beijing Jindu (Nanjing) Law Firm on the 2021 Restricted Stock Incentive Plan Grant Price Adjustment, Achievement of Ownership Conditions during the Third Vesting Period, and Cancellation of Some Restricted Shares
Kibel\'s announcement on adjusting the restricted stock grant price of the 2021 Restricted Stock Incentive Plan
Jiangsu Jibeier Pharmaceutical Co., Ltd. announcement of the implementation of equity distribution in the first quarter of 2024.
Jiangsu Jibeier Pharmaceutical Co., Ltd.'s profit distribution plan announcement for the first quarter of 2024.
Jiangsu Jibeier Pharmaceutical Co., Ltd. issued stocks to specific parties through a simplified process and announced its listing on the STAR Market.
Jiangsu Jibeier Pharmaceutical Co., Ltd.'s announcement regarding the passive dilution of the shareholding percentage of the company's controlling shareholder, actual controller and its concerted action persons by more than 1%.
Sinolink Securities Co., Ltd. on the Listing Sponsorship of the Jiangsu Jibeier Pharmaceutical Co., Ltd.'s Issuance of Shares to Specific Objectives
Announcement of Jiangsu Jibeier Pharmaceutical Co., Ltd. regarding the outcome of issuing stocks to specific objects through simplified procedures and changes in share capital.
Jiangsu Jibeier Pharmaceutical Co., Ltd. issued a stock to specific objects for fundraising verification report.
Legal Opinion of Beijing King & Wood Mallesons on the Process of Jiangsu Jibeier Pharmaceutical Co., Ltd. Issuing Stocks to Specific Objects through Simple Procedures and the Compliance of Subscription Objects
Sinolink Securities Co., Ltd.'s report on the process of stock issuance and compliance of subscription objects by Jiangsu Jibeier Pharmaceutical Co., Ltd. issuing stocks to specific targets through simplified procedures.
Jiangsu Jibeier Pharmaceutical Co., Ltd. issued a report on the issuance of stocks to specific targets using a simplified process.
Jiangsu Jibeier Pharmaceutical Co., Ltd.'s announcement regarding the disclosure of the report on the issuance of stocks to specific objects through simplified procedures.
Legal Opinion of King & Wood Mallesons Beijing Office regarding the issuance of stocks by Jiangsu Jibeier Pharmaceutical Co., Ltd. to specific targets.
Announcement from Jiangsu Jibeier Pharmaceutical Co., Ltd. regarding the approval of registration by the China Securities Regulatory Commission for the issuance of stocks to specific objects through simplified procedures.
Sinolink Securities Co., Ltd.'s issuance sponsor letter for the specific object issuance of stocks by Jiangsu Jibeier Pharmaceutical Co., Ltd.
No Data
No Data